Abstract:Despite the pharmacological arsenal approved for Multiple Sclerosis (MS), there are treatment-reluctant patients for whom cell therapy appears as the only therapeutic alternative. Myeloid-derived suppressor cells (MDSCs) are immature cells of the innate immunity able to control the immune response and to promote oligodendroglial differentiation in the MS animal model experimental autoimmune encephalomyelitis (EAE). However, when isolated and cultured for cell therapy purposes, MDSCs lose their beneficial immunomodulatory properties. To prevent this important drawback, culture devices need to be designed so that MDSCs maintain a state of immaturity and immunosuppressive function similar to that exerted in the donor organism. With this aim, we select graphene oxide (GO) as a promising candidate as it has been described as a biocompatible nanomaterial with the capacity to biologically modulate different cell types, yet its immunoactive potential has been poorly explored to date. In this work, we have fabricated GO films with two distintive redox and roughness properties and explore their impact in MDSC culture right after isolation. Our results show that MDSCs isolated from immune organs of EAE mice maintain an immature phenotype and highly immunosuppressive activity on T lymphocytes after being cultured on highly-reduced GO films (rGO 200 ) compared to those grown on conventional glass coverslips. This immunomodulation effect is depleted when MDSCs are exposed to slightly rougher and more oxidized GO substrates (rGO 90 ), in which cells experience a significant reduction in cell size associated with the activation of apoptosis. Taken together, the exposure of MDSCs to GO substrates with different redox state and roughness is presented as a good strategy to control MDSC activity in vitro . The versatility of GO nanomaterials in regards to the impact of their physico-chemical properties in immunomodulation opens the door to their selective therapeutic potential for pathologies where MDSCs need to be enhanced (MS) or inhibited (cancer).

The therapeutic potential of reduced graphene oxide in attenuating cuprizone-induced demyelination in mice

Graphene oxide films as a novel tool for the modulation of myeloid-derived suppressor cell activity in the context of multiple sclerosis

Comparative Neuroprotective Potential of Nanoformulated and Free Resveratrol Against Cuprizone-Induced Demyelination in Rats

Therapeutic effect of oligomeric proanthocyanidin in cuprizone-induced demyelination.

Correction to Oxidation of Reduced Graphene Oxide Via Cellular Redox Signaling Modulates Actin-Mediated Neurotransmission

Graphene oxide upregulates the homeostatic functions of primary astrocytes and modulates astrocyte-to-neuron communication

Graphene Oxide and Reduced Graphene Oxide Exhibit Cardiotoxicity Through the Regulation of Lipid Peroxidation, Oxidative Stress, and Mitochondrial Dysfunction

Microglial Neuroinflammation-Independent Reversal of Demyelination of Corpus Callosum by Arsenic in a Cuprizone-Induced Demyelinating Mouse Model

Palladium-reduced graphene oxide nanocomposites enhance neurite outgrowth and protect neurons from Ishemic stroke

Radiation induced reduction of Graphene Oxide: a dose effect study

Multisensory gamma stimulation mitigates the effects of demyelination induced by cuprizone in male mice

Graphene oxide nanosheets disrupt lipid composition, Ca2+ homeostasis and synaptic transmission in primary cortical neurons

Quercetin induced biosynthesis of reduced graphene oxide and its application for treatment of lung cancer in nursing care

The Cytotoxic Effectiveness of Thiourea-Reduced Graphene Oxide on Human Lung Cancer Cells and Fungi

A Review of Antioxidant Properties in Graphene Oxide Reduction

Graphene Oxide Improves Postoperative Cognitive Dysfunction by Maximally Alleviating Amyloid Beta Burden in Mice.

Effect of a solvothermal method using DMF on the dispersibility of rGO, application of rGO as a CDI electrode material, and recovery of sp2-hybridized carbon

Transcranial direct current stimulation as a potential remyelinating therapy: Visual evoked potentials recovery in cuprizone demyelination

Methylglyoxal-Mediated Dopamine Depletion, Working Memory Deficit, and Depression-Like Behavior Are Prevented by a Dopamine/Noradrenaline Reuptake Inhibitor

The Influence of Reduced Graphene Oxide on Stem Cells: a Perspective in Peripheral Nerve Regeneration

Graphene Oxide Disrupted Mitochondrial Homeostasis Through Inducing Intracellular Redox Deviation and Autophagy-Lysosomal Network Dysfunction in SH-SY5Y Cells